IP Library Granted Patent US 12,338,264
Granted Patent B2
US 12,338,264 · App. 17/431,825 · Granted Jun 24, 2025

Crystalline potassium salt of 2-O-α-D-glucosyl-L-ascorbic acid and method for producing the same

Inventors: Akiko Miyake (Okayama, JP); Osamu Sano (Okayama, JP); Hirofumi Kunitake (Okayama, JP)
Assignee: Nagase Viita Co., Ltd.
C07H17/04C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,338,264
App. No.
17/431,825
Granted
Jun 24, 2025
Kind
B2
Abstract

The present invention has objects to provide a novel crystalline 2-O-α-D-glucosyl-L-ascorbic acid and method for producing the same. The present invention solves the above objects by providing crystalline potassium salt of 2-O-α-D-glucosyl-L-ascorbic acid and method for producing the same.

Claims (12)

1. A crystalline potassium salt of 2-O-α-D-glucosyl-L-ascorbic acid.

2. The crystalline potassium salt of 2-O-α-D-glucosyl-L-ascorbic acid of claim 1 , which has at least diffraction peaks at diffraction angles (2θ) of 8.27°, 8.81°, 16.05°, 18.88°, and 25.64°, when measured by powder X-ray diffraction analysis.

3. The crystalline potassium salt of 2-O-α-D-glucosyl-L-ascorbic acid of claim 1 , which is in a hydrous crystalline form.

4. A method for producing the crystalline potassium salt of 2-O-α-D-glucosyl-L-ascorbic acid of claim 1 , comprising:

dissolving 2-O-α-D-glucosyl-L-ascorbic acid in a potassium hydroxide aqueous solution, wherein the molar ratio of potassium hydroxide to 2-O-α-D-glucosyl-L-ascorbic acid in the aqueous solution is 2.7 to 5.4;

adding an alcohol to the resulting solution such that the ratio of the alcohol to the 2-O-α-D-glucosyl-L-ascorbic acid is 3;

allowing the resulting mixture to stand; and

collecting the precipitated crystalline potassium salt of 2-O-α-D-glucosyl-L-ascorbic acid in the mixture.

5. The method of claim 4 , wherein said alcohol is methanol or ethanol.

6. A composition, which comprises the crystalline potassium salt of 2-O-α-D-glucosyl-L-ascorbic acid of claim 1 .

7. The composition of claim 6 , which further comprises an anhydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid, wherein the ratio of said anhydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid and said crystalline potassium salt of 2-O-α-D-glucosyl-L-ascorbic acid is in the range of 70:30 to 45:55 by mass.

8. The composition of claim 6 , which is in the form of food and beverage, cosmetic, pharmaceutical, quasi-drug, or industrial product.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Apr 24, 2025
From: MIYAKE, AKIKO; SANO, OSAMU; KUNITAKE, HIROFUMI
To: HAYASHIBARA CO., LTD.
Reel/Frame 070932/0566 →
CHANGE OF NAME Recorded Nov 18, 2024
From: HAYASHIBARA CO., LTD
To: NAGASE VIITA CO., LTD.
Reel/Frame 069379/0708 →
Priority Claims (1)
JP 2019-028755 · Feb 20, 2019 · national
Continuity (1)
Related Publication 20220153773A1 · May 19, 2022
References Cited (24)
US 5137723A · Yamamoto et al. · 1992 [cited by applicant]
US 5432161A · Sakai et al. · 1995 [cited by applicant]
US 20130172542A1 · Shibuya et al. · 2013 [cited by applicant]
US 20150342854A1 · Shibuya et al. · 2015 [cited by applicant]
EP 0487404B1 · 1995 [cited by applicant]
EP 0461827B1 · 1997 [cited by applicant]
JP 3135992A · 1991 [cited by applicant]
JP 3139288A · 1991 [cited by applicant]
JP 3183492A · 1991 [cited by applicant]
JP 446112A · 1992 [cited by applicant]
JP 4182412A · 1992 [cited by applicant]
JP 4182413A · 1992 [cited by applicant]
JP 4182419A · 1992 [cited by applicant]
JP 3290490B2 · 2002 [cited by applicant]
JP WO2014104171A1 · 2014 [cited by examiner]
JP 5856963B2 · 2016 [cited by applicant]
JP WO2018021542A1 · 2018 [cited by examiner]
JP 6307444B2 · 2018 [cited by applicant]
WO 2014104171A1 · 2014 [cited by applicant]
WO 2018021542A1 · 2018 [cited by applicant]
Hirayama, Noriaki, Handbook for preparing crystals of organic compounds, Yukikagoubutsu Kessyou Sakusei Handbook, 2008, pp. 17-23, 37-40, 45-51, 57-65, published by Maruzen Publishing Co., Ltd. [cited by applicant]
Takata, Noriyuki, API form screening and selection in drug discovery stage, Pharm Stage, vol. 6, No. 10, Jan. 15, 2007, pp. 20-25. [cited by applicant]
Wermuth, Medicinal Chemistry the second volume (Saishin Soyaku Kagaku Gekan), 1999, pp. 347-365, published by Technomics, Inc. [cited by applicant]
Japanese Decision of Refusal dated Nov. 15, 2023, from corresponding patent application No. JP2021-501848. [cited by applicant]